Vis enkel innførsel

dc.contributor.authorBjørgaas, Marit Ragnhild Rokne
dc.contributor.authorFarstad, Hanne
dc.contributor.authorChristiansen, Sverre Christian
dc.contributor.authorBlaas, Harm-Gerd Karl
dc.date.accessioned2021-04-16T12:14:49Z
dc.date.available2021-04-16T12:14:49Z
dc.date.created2013-07-24T15:35:19Z
dc.date.issued2013
dc.identifier.citationHormone Research in Paediatrics. 2013, 79 39-43.en_US
dc.identifier.issn1663-2818
dc.identifier.urihttps://hdl.handle.net/11250/2738156
dc.description.abstractBackground: Treatment with radioiodine for Graves’ disease regularly increases the level of antithyroid antibodies, and transplacental passage of stimulating thyrotropin receptor antibodies (TRAb) may cause fetal hyperthyroidism. Case presentation: A 21-year-old woman with Graves’ disease received radioiodine treatment to avoid use of antithyroid drugs in pregnancy. She became pregnant 4 months later and was euthyroid during pregnancy. In gestational week (GW) 33, she was admitted with an increased fetal heart rate of 176–180 beats/min. Fetal echocardiography indicated cardiac decompensation. The neonate had severe hyperthyroidism (free thyroxine >100 pmol/l, nv 12.0–22.0), cardiac insufficiency, insufficient weight gain, goiter and considerably accelerated skeletal age. In the mother and neonate, TRAb was >40 IU/l (nv <1.0), indicating transplacental passage of stimulating antibodies. After delivery, TRAb remained >40 IU/l in the woman, and 18 months later she underwent total thyroidectomy with subsequent decline in TRAb. In her next pregnancy, TRAb fluctuated between 38 and 17 IU/l, and repeated fetal ultrasound showed no goiter or sign of hyperthyroidism. In cord blood, TRAb was 10.9 IU/l, and the neonate had normal thyroid hormone levels. Conclusion: This case report illustrates the impact of maternal TRAb level for neonatal outcome in two successive pregnancies.en_US
dc.language.isoengen_US
dc.publisherKarger Publishersen_US
dc.relation.urihttps://www.karger.com/Article/FullText/342644
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleImpact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' Diseaseen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber39-43en_US
dc.source.volume79en_US
dc.source.journalHormone Research in Paediatricsen_US
dc.identifier.doi10.1159/000342644
dc.identifier.cristin1040218
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal